Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation.

Genome Med 2016 07 11;8(1):74. Epub 2016 Jul 11.

HudsonAlpha Institute for Biotechnology, Huntsville, AL, 35806, USA.

Background: The liver X receptors (LXRs, NR1H2 and NR1H3) and peroxisome proliferator-activated receptor gamma (PPARG, NR1C3) nuclear receptor transcription factors (TFs) are master regulators of energy homeostasis. Intriguingly, recent studies suggest that these metabolic regulators also impact tumor cell proliferation. However, a comprehensive temporal molecular characterization of the LXR and PPARG gene regulatory responses in tumor cells is still lacking.

Methods: To better define the underlying molecular processes governing the genetic control of cellular growth in response to extracellular metabolic signals, we performed a comprehensive, genome-wide characterization of the temporal regulatory cascades mediated by LXR and PPARG signaling in HT29 colorectal cancer cells. For this analysis, we applied a multi-tiered approach that incorporated cellular phenotypic assays, gene expression profiles, chromatin state dynamics, and nuclear receptor binding patterns.

Results: Our results illustrate that the activation of both nuclear receptors inhibited cell proliferation and further decreased glutathione levels, consistent with increased cellular oxidative stress. Despite a common metabolic reprogramming, the gene regulatory network programs initiated by these nuclear receptors were widely distinct. PPARG generated a rapid and short-term response while maintaining a gene activator role. By contrast, LXR signaling was prolonged, with initial, predominantly activating functions that transitioned to repressive gene regulatory activities at late time points.

Conclusions: Through the use of a multi-tiered strategy that integrated various genomic datasets, our data illustrate that distinct gene regulatory programs elicit common phenotypic effects, highlighting the complexity of the genome. These results further provide a detailed molecular map of metabolic reprogramming in cancer cells through LXR and PPARG activation. As ligand-inducible TFs, these nuclear receptors can potentially serve as attractive therapeutic targets for the treatment of various cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13073-016-0328-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940857PMC
July 2016
22 Reads

Publication Analysis

Top Keywords

gene regulatory
20
cell proliferation
12
nuclear receptors
12
lxr pparg
12
liver receptors
8
nuclear receptor
8
cancer cells
8
metabolic reprogramming
8
distinct gene
8
regulatory programs
8
regulatory
6
gene
6
pparg
6
nuclear
5
receptors
5
decreased glutathione
4
levels consistent
4
inhibited cell
4
glutathione levels
4
illustrate activation
4

Altmetric Statistics

References

(Supplied by CrossRef)
Article in Genome Res
LT Macneil et al.
Genome Res 2011
Article in Trends Biochem Sci
HR Herschman et al.
Trends Biochem Sci 1989
Article in Nat Rev Genet
L Lopez-Maury et al.
Nat Rev Genet 2008
Article in Cell
M Bulger et al.
Cell 2011
Article in Genome Biol
NJ Sakabe et al.
Genome Biol 2012
Article in Curr Biol
M Levine et al.
Curr Biol 2010
Article in Cell
R Tjian et al.
Cell 1994
Article in Nat Rev Mol Cell Biol
AC Calkin et al.
Nat Rev Mol Cell Biol 2012
Article in Annu Rev Med.
J Berger et al.
Annu Rev Med. 2002
Article in J Lipid Res
AC Li et al.
J Lipid Res 2004

Similar Publications